RATS IMMUNIZED WITH CHOLINERGIC SYNAPTOSOMES - A MODEL FOR LAMBERT-EATON SYNDROME

被引:5
|
作者
CHAPMAN, J
RABINOWITZ, R
KORCZYN, AD
MICHAELSON, DM
机构
[1] TEL AVIV UNIV,SACKLER SCH MED,DEPT PHYSIOL & PHARMACOL,IL-69978 TEL AVIV,ISRAEL
[2] TEL AVIV UNIV,DR GEORGE S WISE CTR LIFE SCI,DEPT BIOCHEM,TEL AVIV,ISRAEL
关键词
acetylcholine release; autoantibodies; electromyography; Lambert‐Eaton myasthenic syndrome; Torpedo;
D O I
10.1002/mus.880130811
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lambert‐Eaton myasthenic syndrome (LEMS) is an autoimmune disorder characterized by reduced acetylcholine release at the neuromuscular junction. We report a model of the disease developed by active immunization of rats with purely cholinergic nerve terminals (synaptosomes) isolated from the Torpedo electric organ. Electromyographic studies of neuromuscular transmission in these rats showed a weak initial response followed by a pronounced incremental response to paired supramaximal stimuli (8 msec apart). There was no such response in control rats. There was no evidence of a postsynaptic transmission deficit in the synaptosomes immunized rats. We conclude that immunizing rats with Torpedo cholinergic nerve terminals causes a specific presynaptic dysfunction and may serve as a model for the study of LEMS. Copyright © 1990 John Wiley & Sons, Inc.
引用
收藏
页码:726 / 733
页数:8
相关论文
共 50 条
  • [31] Distribution of electrophysiological abnormality in Lambert-Eaton myasthenic syndrome
    Maddison, P
    Newsom-Davis, J
    Mills, KR
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 65 (02) : 213 - 217
  • [32] Wilms Tumor Presenting With Lambert-Eaton Myasthenic Syndrome
    Petersen, Cheryl L.
    Hemker, Bradd G.
    Jacobson, Richard D.
    Warwick, Anne B.
    Jaradeh, Safwan S.
    Kelly, Michael E.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (04) : 267 - 270
  • [33] Lambert-Eaton myasthenic syndrome - Report of two cases
    Scola, RH
    Iwamoto, FM
    Ramos, CS
    Sanderson, AM
    Lopardo, D
    Cantarelli, A
    Watanabe, M
    Horta, W
    Werneck, LC
    ARQUIVOS DE NEURO-PSIQUIATRIA, 1998, 56 (3A) : 457 - 464
  • [34] Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome
    Oh, SJ
    Kurokawa, K
    Claussen, GC
    Ryan, HF
    MUSCLE & NERVE, 2005, 32 (04) : 515 - 520
  • [35] Lambert-Eaton Myasthenic syndrome in a child with an autoimmune phenotype
    Hoffman, WH
    Helman, SW
    Sekul, E
    Carroll, JE
    Vega, RA
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 119A (01) : 77 - 80
  • [36] Presynaptic Disorders: Lambert-Eaton Myasthenic Syndrome and Botulism
    Gable, Karissa L.
    Massey, Janice M.
    SEMINARS IN NEUROLOGY, 2015, 35 (04) : 340 - 346
  • [37] Amifampridine tablets for the treatment of Lambert-Eaton myasthenic syndrome
    Mantegazza, Renato
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (11) : 1013 - 1018
  • [38] Lambert-Eaton myasthenic syndrome - Diagnosis, pathogenesis and therapy
    Huelsbrink, Robert
    Hashemolhosseini, Said
    CLINICAL NEUROPHYSIOLOGY, 2014, 125 (12) : 2328 - 2336
  • [39] Lambert-Eaton myastenic syndrome revealing neuroblastoma in 2 children
    Bosdure, E.
    Attarian, S.
    Mancini, J.
    Mikaeloff, Y.
    Chabrol, B.
    ARCHIVES DE PEDIATRIE, 2006, 13 (08): : 1121 - 1124
  • [40] Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome
    Oh, Shin J.
    Hatanaka, Yuki
    Claussen, Gwen C.
    Sher, Emanuele
    MUSCLE & NERVE, 2007, 35 (02) : 178 - 183